Huber Martin H. Jr.

President, CEO at Mersana Therapeutics, Inc.; SVP & Chief Medical Officer at TESARO, Inc.

Sold, on record
$850k
Dollars the filings state
Form 4 sales
12
Latest Sep 12, 2025
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale TESARO, Inc.Plan not stated
    Sep 22, 2017 2017

    Sold 592 shares at $118.60 ($70k)

    Huber Martin H. Jr., SVP & Chief Medical Officer

    Sold 8.5% of holdings ($823k position)6,351 shares left1.5x usual sizeFiling

  2. 2 Form 4 sale TESARO, Inc.Plan not stated
    Dec 4, 2017 +73 days

    Sold 829 shares at $85.24 ($71k)

    Huber Martin H. Jr., SVP & Chief Medical Officer

    Sold 10.2% of holdings ($691k position)7,272 shares left1.7x usual sizeFiling

  3. 3 Form 4 sale TESARO, Inc.Unusual
    Mar 2, 2018 +88 days

    Sold 1,803 shares at $54.86 ($99k)

    Huber Martin H. Jr., SVP & Chief Medical Officer

    Sold 13.7% of holdings ($720k position)11,327 shares left3x usual sizeFiling

  4. 4 Form 4 sale TESARO, Inc.Plan not stated
    Sep 24, 2018 +206 days

    Sold 371 shares at $37.63 ($14k)

    Huber Martin H. Jr., SVP & Chief Medical Officer

    Sold 2.9% of holdings ($473k position)12,206 shares left0.4x usual sizeFiling

  5. 5 Form 4 sale Mersana Therapeutics, Inc.Routine
    Sep 12, 2024 +2180 days

    Sold 50,423 shares at $1.76 ($89k)

    Huber Martin H. Jr., President, CEO

    10b5-1 planSold 30.2% of holdings ($293k position)116,327 shares leftFirst sale on recordFiling

  6. 6 Form 144 notice Mersana Therapeutics, Inc.Notice
    Sep 13, 2024 +1 day

    Filed to sell 50,423 shares ($89k)

    Huber Martin H. Jr., Officer, Director

    10b5-1 planFiling

  7. 7 Form 4 sale Mersana Therapeutics, Inc.Routine
    Jan 16, 2025 +125 days

    Sold 4,514 shares at $0.58 ($3k)

    Huber Martin H. Jr., President, CEO

    10b5-1 planSold 3.5% of holdings ($74k position)122,875 shares leftFiling

  8. 8 Form 4 sale Mersana Therapeutics, Inc.Routine
    Sep 12, 2025 +239 days

    Sold 2,012 shares at $7.31 ($15k)

    Huber Martin H. Jr., President, CEO

    10b5-1 planSold 17.4% of holdings ($85k position)9,572 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Huber Martin H. Jr.
Source
Sep 12, 2025Sep 15, 2025Mersana Therapeutics, Inc.President, CEOForm 4 sale2,012$15k17.4%RoutineSEC
Jan 16, 2025Jan 17, 2025Mersana Therapeutics, Inc.President, CEOForm 4 sale4,514$3k3.5%RoutineSEC
Sep 13, 2024Sep 13, 2024Mersana Therapeutics, Inc.Officer, DirectorForm 144 notice50,423$89kNoticeSEC
Sep 12, 2024Sep 13, 2024Mersana Therapeutics, Inc.President, CEOForm 4 sale50,423$89k30.2%RoutineSEC
Sep 24, 2018Sep 25, 2018TESARO, Inc.SVP & Chief Medical OfficerForm 4 sale371$14k2.9%Plan not statedSEC
Mar 2, 2018Mar 5, 2018TESARO, Inc.SVP & Chief Medical OfficerForm 4 sale1,803$99k13.7%UnusualSEC
Dec 4, 2017Dec 5, 2017TESARO, Inc.SVP & Chief Medical OfficerForm 4 sale829$71k10.2%Plan not statedSEC
Sep 22, 2017Sep 25, 2017TESARO, Inc.SVP & Chief Medical OfficerForm 4 sale592$70k8.5%Plan not statedSEC
Apr 3, 2017Apr 4, 2017TESARO, Inc.SVP & Cheif Medical OfficerForm 4 sale829$127k12.7%Plan not statedSEC
Mar 2, 2017Mar 3, 2017TESARO, Inc.Sr. VP, Chief Medical OfficerForm 4 sale1,428$254k23.0%UnusualSEC
Jan 3, 2017Jan 3, 2017TESARO, Inc.SVP & Chief Medical OfficerForm 4 sale190$26kPlan not statedSEC
Nov 2, 2016Nov 3, 2016TESARO, Inc.SVP & Chief Medical OfficerForm 4 sale327$40k17.8%Plan not statedSEC
Sep 22, 2016Sep 23, 2016TESARO, Inc.SVP & Chief Medical OfficerForm 4 sale408$44k32.6%UnusualSEC